JBIR-14-a highly oxygenated ergostane J-y Ueda et al
Many proteins linked with accelerated proliferation of human cancer cells repress the growth of yeast. [1] [2] [3] The inhibitors of these human proteins can restore the inhibition of yeast proliferation with these human proteins, such as Cdk4, PTEN and poly(ADP-ribose) polymerase; 4 therefore, these observations have led to the development of a cell-based high-throughput screening system for anticancer drugs. Our group has revealed that a previously uncharacterized protein, termed dynAP (dynactin-associating protein), inhibits the growth of a mutant budding yeast lacking Mad2, a principal component of mitotic checkpoint, but does not affect the growth of wild-type yeast. 5 DynAP is localized in Golgi and plasma membrane and interacts with dynactin components; it thus forms a complex and acts as a minus end-directed microtubule motor. Furthermore, dynAP expresses in approximately 50% of human cancer cell lines, contrary to its lowlevel expression in normal cells. Thus, dynAP could be a new target of anticancer drug discovery.
Inhibitors of dynAP could be discovered by monitoring the restoration of dynAP-induced growth inhibition of the mutant yeast lacking Mad2. In the course of our screening program for inhibitors of dynAP, the culture extract of an entomopathogenic fungus, Isaria sp. NBRC 104353, exhibited the restoration of dynAP-induced growth inhibition. We isolated a new steroidal compound, named JBIR-14 (1), by activity-guided isolation from the culture extract of Isaria sp. NBRC 104353 (Figure 1a) . We report herein the fermentation, isolation and structure elucidation of 1.
Isaria sp. NBRC 104353, purchased from the National Institute of Technology and Evaluation (Tokyo, Japan), was cultivated in 50 ml test tubes containing 15 ml of potato dextrose broth (24 g l -1 potato dextrose; BD Biosciences, San Jose, CA, USA). The test tubes were shaken in a reciprocal shaker (355 r.p.m.) at 27 1C for 3 days. Aliquots (1 ml) of the culture were transferred to 100 ml Erlenmeyer flasks containing a medium consisting of 3 g oatmeal (Quaker, Chicago, IL, USA) and 10 ml V8 Mix Juice (Campbell Soup Company, Camden, NJ, USA) and were incubated in static culture at 27 1C for 14 days.
The culture (20 flasks) was extracted with 80% aq. Me 2 CO. After concentration in vacuo, the aqueous concentrate was extracted with EtOAc (100 mlÂ3). The organic layer was dried over Na 2 SO 4 and then evaporated to dryness. The dried residue (0.58 g) was subjected to normal-phase medium-pressure liquid chromatography (MPLC; Purif-Pack SI 60 mm, size: 60 (26.5 i.d.Â100 mm), Moritex, Tokyo, Japan) and eluted with a stepwise system of n-hexane-EtOAc and CHCl 3 -MeOH, successively, to yield an active fraction (73.0 mg) in CHCl 3 -MeOH (19:1) eluate. The active fraction was rechromatographed on the normal-phase column (Purif-Pack SI 60 mm, size: 20 (20 i.d. Â60 mm) with CHCl 3 -MeOH (99:1, 49:1, successively). Finally, the active fraction (9.5 mg) was purified by preparative reverse-phase HPLC using a Senshu Pak PEGASIL ODS column (20 i.d. Â150 mm; Senshu Scientific, Tokyo, Japan) developed with 80% MeOH-H 2 O including 0.1% formic acid (flow rate: 10 ml min -1 ) to yield 1 (3.4 mg, retention time 19.7 min).
Compound 1 Figure 1b 2) elucidated the connectivity among the three substructures, decalin, hydroxymethine and hydroxypropane, in the steroid nucleus. Finally, the remaining 3,4-epoxy-5,6-dimethylhept-2-yl substructure was determined to be attached to C-17 as revealed by 1 H-13 C long-range couplings from 20-H, 21-H and 22-H to C-17. Thus, the planar structure of 1 was determined as shown in Figure 1a .
Relative configuration was assigned on the basis of coupling constants and the analysis of a rotating-frame Overhauser enhancement spectroscopy experiment. The large coupling constants for J 2bH,3H (11.0 Hz) and J 3H,4bH (11.0 Hz) and for the rotating-frame Overhauser enhancement spectroscopy correlations (Figure 1c ) between 1-aH and 3-H; between 2-bH and 19-H; and between 4-bH and 19-H indicated that ring-A should be in a chair conformation with the hydroxyl groups at C-3 in b-equatorial orientation and with the methyl group (C-19) at C-10 in b-axial orientation. On the other hand, the rotatingframe Overhauser enhancement spectroscopy correlations between 1-aH and 9-H; between 9-H and 15-aH; and between 9-H and 17-aH revealed that the ring junction proton 9-H is located in a-axial orientation. Further, the rotating-frame Overhauser enhancement spectroscopy correlations between  and between 18-H and 21-H revealed that the three hydroxyl groups at C-12, C-14 and C-16, the methyl group (C-18) at C-13 and the side chain at C-17 are in b-orientation, but that of C-28 was not determined. Thus, the structure of 1 was established as (3b,12b,14b,16b)-22,23-epoxy-3,12,14,16-tetrahydroxyergosta-5,7-dien-11-one (Figure 1) .
Compound 1 restored the dynAP-induced growth inhibition of Mad2-lacking mutant yeast at a concentration of 25 mM (Figure 2) . Furthermore, compounds related to 1 induced dynAP-mediated Golgi fragmentation and apoptosis in human cancer cells. 5 Thus, 1 may serve as an important compound for developing anticancer drugs and also as a valuable tool for conducting studies on the action mechanism of dynAP. The detailed biological activity and the structure-activity relationship of 1 will be reported elsewhere. 5 Table 1 
